VCYT — VERACYTE, INC.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1384101 ·
Last close
$55.71
Market Cap
$4.45B
52W High
$60.91
52W Low
$31.57
ADV30
1,257,358
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 139,071,000 | 101,159,000 | 22,646,000 | 28,707,000 | 1,436,400,000 | 263,136,000 | 91,994,000 |
| Dec 2025 | 140,636,000 | 101,973,000 | 39,908,000 | 41,149,000 | 1,406,019,000 | 362,578,000 | 96,443,000 |
| Sep 2025 | 131,872,000 | 91,282,000 | 23,112,000 | 19,137,000 | 1,367,787,000 | 315,573,000 | 110,120,000 |
| Jun 2025 | 130,164,000 | 89,769,000 | 14,312,000 | -980,000 | 1,344,104,000 | 219,499,000 | 123,047,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$136,307,000
Investing CF
$-9,209,000
Financing CF
$-4,222,000
CapEx
$-9,677,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.83
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-377,630,000
Inventory
$20,546,000
Receivables
$44,660,000
ST Investments
$50,311,000
EBIT TTM
$61,937,000
Pretax Income TTM
$68,201,000
Interest Exp TTM
$0
Analysts
11
Yahoo Snapshot (yfinance, live)
Total Revenue
$561,900,032
EBITDA
$111,304,000
Free Cash Flow
$99,944,376
Enterprise Value
$4,335,624,192
Total Cash
$485,232,000
Total Debt
$40,107,000
Shares Out
79,792,647
Trailing EPS
$1.08
Book Value
$16.50
ROE
8.8%
ROA
4.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 517,145,000 | 78,282,000 | 66,353,000 | 1,406,019,000 | 96,443,000 | — | 136,307,000 |
| Dec 2024 | 445,764,000 | 19,510,000 | 24,138,000 | 1,300,035,000 | 124,069,000 | — | 75,096,000 |
| Dec 2023 | 361,051,000 | -17,446,000 | -74,404,000 | 1,114,906,000 | 70,804,000 | — | 44,222,000 |
| Dec 2022 | 296,536,000 | -35,340,000 | -36,560,000 | 1,156,422,000 | 81,222,000 | — | 7,535,000 |
TTM Snapshot
Revenues TTM
$341,930,000
NetIncome TTM
$-37,315,000
OpCashFlow TTM
$0
Assets (Latest)
$1,300,035,000
Forward EPS
$1.89
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CAI | Caris Life Sciences, Inc. | $4.41B | $15.59 | — |
| LFST | LifeStance Health Group, Inc. | $4.15B | $10.86 | — |
| CELC | Celcuity Inc. | $4.06B | $83.26 | — |
| CON | Concentra Group Holdings Parent, Inc. | $4.04B | $31.61 | — |
| RDNT | RadNet, Inc. | $4.98B | $63.37 | — |
News headlines (Yahoo Finance, 1h cache)
Is Veracyte (VCYT) Fully Valued After Raising 2026 Revenue Guidance?
2026-07-31 10:06 · Yahoo
Veracyte Inc (VCYT) (Q2 2026) Earnings Call Highlights: Record Revenue and Strategic Launches ...
2026-07-31 05:03 · Yahoo
Veracyte (VCYT) Q2 Earnings and Revenues Surpass Estimates
2026-07-30 22:00 · Yahoo
Veracyte Announces Second Quarter 2026 Financial Results
2026-07-30 20:05 · Yahoo
Veracyte (VCYT) Rises with Upward Guidance Revision and Earnings Beat
2026-07-30 13:17 · Yahoo
Veracyte to Participate in Upcoming Investor Conferences
2026-07-28 20:05 · Yahoo
Analysts Estimate TransMedics (TMDX) to Report a Decline in Earnings: What to Look Out for
2026-07-28 14:00 · Yahoo
Earnings Preview: Veracyte (VCYT) Q2 Earnings Expected to Decline
2026-07-23 14:00 · Yahoo
RxSight (RXST) Surges 6.1%: Is This an Indication of Further Gains?
2026-07-17 07:50 · Yahoo
Veracyte to Release Second Quarter 2026 Financial Results on July 30, 2026
2026-07-09 20:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.